ProShare Advisors’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-26,713
Closed -$2.68M 1913
2015
Q1
$2.68M Buy
26,713
+6,450
+32% +$430K 0.03% 476
2014
Q4
$1.06M Buy
+20,263
New +$595K 0.01% 825

ProShare Advisors's ASPX Position: Q2 2015 in Review

ProShare Advisors sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 26,713 shares — an estimated $2.68M sold.

ProShare Advisors first reported a position in ASPX in Q4 2014 and held it in 2 quarters. The position peaked at $2.68M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • ProShare Advisors reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • ProShare Advisors sold 26,713 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $2.68M.
  • ProShare Advisors first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • ProShare Advisors's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $2.68M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.